New Target for ‘Triple-negative’ Breast Cancer Discovered

News   Nov 21, 2017 | Original story from University of Virginia

 
New Target for ‘Triple-negative’ Breast Cancer Discovered

Biomedical engineering professor Kevin Janes and colleagues are looking for an end-around path to solving the triple-negative breast cancer puzzle. Photo Credit: Dan Addison, University Communications

 
 
 

RELATED ARTICLES

Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

News

Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.

READ MORE

Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity Treatment

News

An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.

READ MORE

Gene Therapy Could End Transfusions for Blood Disorder Patients

News

Beta-thalassemia patients need a regular dose of red blood cells transfused into their body. A new gene therapy that edits faulty genes in the patients' cells could end this monthly ritual.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE